ASI
Live / Applied — Statement of use — registration review complete (as of 15 Mar 2026)
What this means for you
Not registered yet, but its 21 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98460081
- Mark type
- Stylized text
- Filed
- 21 Mar 2024
- Published for opposition
- 05 Nov 2024
- Attorney of record
- Chris Pei-Hsun Cheng
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting metabolism
Owner
- Seragon Pharmaceuticals Inc., Irvine, CA, US
- Seragon Pharmaceuticals Inc., Irvine, CA, US
Prosecution history
- 15 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jan 2026 — USE AMENDMENT FILED
- 26 Jan 2026 — SOU EXTENSION 2 GRANTED
- 16 Dec 2025 — SOU EXTENSION 2 FILED
- 19 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 19 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 19 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 19 Jan 2026 — PETITION TO REVIVE-GRANTED
- 19 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 19 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED